Close

Pfizer (PFE) Secures Priority Review Designation and New Drug Application Acceptance for Glasdegib

June 27, 2018 8:04 AM EDT Send to a Friend
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted the company’s New Drug Application ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login